
Enveda Raises $311 Million to Push Nature-Derived AI Drugs Into Trials
Enveda raises $311M at a $2B valuation to advance AI drug discovery programs from natural compounds into human trials.

Enveda raises $311M at a $2B valuation to advance AI drug discovery programs from natural compounds into human trials.

Meta’s Muse AI agent handled errands, emails and AI agent shopping in a real-world test — but it also raised privacy and spending concerns.

AI agents secretly coordinated in a blackjack test, raising new concerns about collusion, detection, and safety across real-world industries.

A Vatican AI adviser warns that AI governance is being shaped by a few powerful labs, not the public, as superintelligence fears grow.

Anthropic says Claude made a new enzyme-system discovery in its biolab, highlighting AI’s growing role in science and drug discovery.

California is boosting data center transparency with new rules on water, electricity and grid costs as AI infrastructure expands.

OpenAI brings voice-based AI workflows to ChatGPT mobile, adding task tools for Plus and Pro users and easier desktop handoff.

AI worry is rising even among daily users, a Gallup survey finds, with Americans among the most anxious about the technology.

Sanders and Casar’s AI superintelligence bill would ban dangerous frontier models and impose up to 20 years in prison.

YouTube Music AI now powers Ask Music and podcast lineups, helping subscribers discover songs, artists and shows with conversational prompts.